Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma

Research output: Contribution to journalLetterOtherpeer-review

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)667-668
Number of pages2
JournalAnnals of Hematology
Volume95
Issue number4
DOIs
Publication statusPublished - 1 Mar 2016

Cite this

@article{6e8b8ac1ee654edd8c33760259e8d2ec,
title = "Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma",
author = "Fedele, {Pasquale L.} and Gregory, {Gareth P.} and Michael Gilbertson and Jake Shortt and Beena Kumar and Stephen Opat and George Grigoriadis",
year = "2016",
month = "3",
day = "1",
doi = "10.1007/s00277-016-2601-6",
language = "English",
volume = "95",
pages = "667--668",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer-Verlag London Ltd.",
number = "4",

}

TY - JOUR

T1 - Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma

AU - Fedele, Pasquale L.

AU - Gregory, Gareth P.

AU - Gilbertson, Michael

AU - Shortt, Jake

AU - Kumar, Beena

AU - Opat, Stephen

AU - Grigoriadis, George

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84959509739&partnerID=8YFLogxK

U2 - 10.1007/s00277-016-2601-6

DO - 10.1007/s00277-016-2601-6

M3 - Letter

VL - 95

SP - 667

EP - 668

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 4

ER -